DexCom, Inc.DXCMNASDAQ
Loading
R&D Expense Growth Under PressureDecelerating
Percentile Rank21
5Y CAGR-23.2%
Year-over-Year Change
Year-over-year research & development expense growth
5Y CAGR
-23.2%/yr
Long-term compound
Percentile
P21
Within normal range
vs 5Y Ago
0.3x
Contraction
Streak
1 yr
Consecutive declineDecelerating
| Period | Value |
|---|---|
| 2025 | 8.45% |
| 2024 | 9.21% |
| 2023 | 4.46% |
| 2022 | -19.86% |
| 2021 | 67.88% |
| 2020 | 31.59% |
| 2019 | -34.48% |
| 2018 | 125.13% |
| 2017 | 18.77% |
| 2016 | 13.53% |